Fueling progress in biopharma and medtech through innovation, capital, and collaborative efforts.
Louis Pasteur – French chemist and microbiologist whose pioneering work in germ theory, vaccination, and pasteurization transformed medicine
Accelerating biopharma and medtech advancements through innovation, capital, and partnerships.
Science knows no country, because knowledge belongs to humanity, and is the torch which illuminates the world.”— Louis Pasteur
ALISO VIEJO, CA, UNITED STATES, August 3, 2026 /EINPresswire.com/ — GenBio Inc., a biotechnology firm specializing in the discovery and creation of new therapeutics and naturally derived bioactive technologies, announced today its involvement in the launch of the Asia-Pacific partnering program, a gathering where biopharmaceutical firms, investors, research entities, and strategic allies come together to explore fresh collaborations and commercialization pathways.
With partnering activities now underway, GenBio is connecting with organizations that are seeking cutting-edge scientific platforms, distinctive intellectual property, and strategic growth prospects within the biotech and pharma sectors.
"Our goal is to forge meaningful connections with organizations that appreciate the value of rigorous scientific inquiry and joint innovation," stated Giles Tilley, Chief Executive Officer of GenBio Inc. "The Asia-Pacific region remains a key driver of biotechnology progress, and we anticipate fruitful conversations with potential strategic partners who align with our enduring vision."
GenBio's research initiatives focus on the identification, characterization, and development of naturally sourced bioactive compounds with potential uses in infectious disease, inflammation, immune health, and related therapeutic fields. The Company continues to push its scientific programs forward through collaborations with top-tier research institutes and industry experts, all while broadening its intellectual property holdings.
Taking part in this year's partnering meetings marks another milestone in GenBio's overall strategy to cultivate relationships with pharmaceutical companies, biotech innovators, contract research organizations, manufacturers, and institutional investors interested in advancing promising scientific discoveries toward commercial application.
Throughout the partnering event, GenBio will showcase its scientific platform, development roadmap, and corporate vision to qualified organizations seeking opportunities for collaboration, strategic investment, licensing, co-development, or broader corporate transactions.
"As biotechnology progresses through collaboration, we believe the most impactful innovations arise when scientific excellence is paired with seasoned development partners," added Todd D. Sonoga, Director and Chief Marketing Officer of GenBio Inc. "We are enthusiastic about initiating discussions that could accelerate the development of technologies inspired by nature and refined through science."
Organizations interested in arranging meetings with GenBio during the partnering event are encouraged to use the conference partnering platform or visit www.GenBioInc.com for further details.
About GenBio Inc.
GenBio Inc. is a biotechnology company committed to discovering, identifying, refining, and developing naturally derived bioactive technologies with potential applications in human health. Through scientific collaboration, intellectual property development, and strategic alliances, the Company aims to advance innovative therapeutic and wellness technologies from discovery to commercialization.
Developed by Nature.
Identified.
Refined.
Formulated by GenBio.
